I really think that we all know and many experts around the world have confirmed that many foods, herbs, and other plants are very effective at killing cancer cells in the lab. Well, probably the best known example is cannabis, whose active constituents, cannabinoids, have been shown to annihilate cancers of all different kinds. The trouble has been understanding the various strains and quality of cannabis and how it interacts with each person differently. Clinical trials would help, but there have been few.
But, did you know that the (little-known) Chinese herb artemisinin is another good example? Well yes, and according to studies published in Life Sciences, Cancer Letters, and Anticancer Drugs, this derivative of the wormwood plant, commonly used in Chinese medicine, can kill off cancer cells, and do it at a rate of 12,000 cancer cells for every healthy cell. This is really amazing, right?
Another, ancient plant, which was used medicinally by many different civilizations is now proving effective as well. Does the name Noni Leaf ring any bell? Here’s what you need to know – it’s derived from a small evergreen tree which grows in the Pacific Islands, Southeast Asia, Australia, and India among lava flows. It has been studied for its numerous health benefits, and a fairly recent study published in Molecular and Cellular Biochemistry is showing that this food, consumed as a vegetable (Noni Leaves), could be ideal for the treatment, prevention, and/or management of lung cancer.
Note: you should also know that this study has discovered that an extract of Noni leaf was more effective than Erlotinib, the chemotherapy drug used for suppressing metastasized lung cancer, at treating lung cancer in an animal model.The researchers in this study also point out how conventional chemotherapy and/or radiotherapy commonly fails when it comes to lung cancer. And this isn’t new information.
A survey conducted in 1985 found that only about one-third of physicians and oncology nurses would have consented to chemotherapy for non-small-cell lung cancer (NSCLC). According to the latest statistics, the medical experts say that lung cancer is the most lethal of all cancers, claiming 1.4 million lives every year, and the majority of these cases are classified as NSCLC.
This is the main reason why the experts compared Noni leaves on metastasized lung cancer development, both in vitro and in vivo, with the FDA-approved anti-cancer drug Erlotinib.
So, now you probably ask yourself – what’s the difference between in vivo and in vitro studies? Here’s what you need to know:
- For in vitro studies – researchers conduct experiments using cells in a petrie dish, or perform a procedure in a controlled environment outside of a living organism.
- For in vivo studies – researchers perform experiments on a whole, living organism as opposed to a partial or dead organism. Animal studies and clinical trials are two forms of in vivo research.
You should also know that this study has discovered that Noni leaf extract “inhibited the proliferation and induced apoptosis in A549 cells and mouse Lewis lung carcinoma cells in vitro [and] arrested cancer cell cycle at G0/G1 phases.”
The abstract goes on to further outline the results:
- First, you should know that it showed no toxicity on normal lung cells, and mentioned that: Non-small-cell lung cancer (NSCLC) A549-induced BALB/c mice were fed with 150 and 300 mg/kg M. centifolia and compared with Erlotinib (50mg/kg body weight) for 21 days.
- It significantly increased the pro-apoptic TRP53 genes, down regulated the pro-tumorigenesis genes in the mice tumors, significantly increased the anti-inflammatory IL4, IL10 and NR3C1 expression in the metastasized lung and hepatic cancer tissues and enhanced the NFE2L2-dependent antioxidant responses against oxidative injuries.
- The extract elevated serum neutrophils and reduced the red blood cells, hemoglobin, corpuscular volume and cell hemoglobin concentration in the lung cancer-induced mammal.
- It suppressed inflammation and edema, and upregulated the endogenous antioxidant responses and apoptotic genes to suppress the cancer.
- Note: you should also know that the 300 mg/kg extract was more effective than the 50 mg/kg Erlotinib for most of the parameters measured.
This is really amazing, isn’t it? These findings definitely warrant further research and human clinical trials. The changes produced by Noni leaf are consistent with what researchers would expect from a good chemotherapy drug, so why this type of medicine is classified as ‘alternative’ is a mystery. In fact, 25 percent of the active ingredients in cancer drugs are found only in the Amazon, yet only 10 percent of the plants in the Amazon have been studied for their medicinal properties.
And I really think that there’s one thing we all can agree on – cancer is a big business, promising huge and endless profits for pharmaceutical companies. Agree? This is far from a conspiracy theory; there is a reason why so many experts in the field are speaking out against the cancer industry. Linus Pauling, for example, a two time Nobel Prize winner, told the world that most cancer research is largely a fraud, and that the major cancer research organizations are “derelict in their duties to the people who support them.”
The famous professor Arnold Seymour Relman (1923-2014), a professor of medicine at Harvard University and the former editor-in-chief of the New England Medical Journal, said that the medical profession is being bought by the pharmaceutical industry, not only in terms of the practice of medicine, but also in terms of teaching and research. The academic institutions of this country are allowing themselves to be the paid agents of the pharmaceutical industry. He also said that the list of statements from industry insiders is extensive, and the number of substances out there showing extreme potential for cancer treatment is similarly large. Unfortunately, pharmaceutical companies don’t seem to be interested in many of them, since most can’t be patented or profited from.
Another famous expert, Sayer Ji from Green-med-info, said that the implications of this research are truly profound. Sayer also said that Erlotinib (trade name Tarceva) can cost upwards of $7,700 a month (150 mg a day), depending on the drug dose used. This is really bad, because the drug doesn’t actually prolong survival effectively, the profit gravy train runs dry sooner than later because the patient dies. If indeed the drug prolonged survival a year, would it be worth the 30,000 to 90,000 it costs? Well maybe, but only if you could afford it.
And, when you compare the price of Noni leaf extract, which can cost as low as 12 cents per 250 mg extract, you begin to see just how skewed our concept of value is. How could a chemotherapy agent, with deadly side effects, that can easily bankrupt a family if they are forced to pay out of pocket, be offered as the only choice to those with cancer when something that is practically free, safe, and has been proven effective in this way? Just think about it! We really hope you find this article helpful and don’t forget to share it with your friends and family. Thank You.